CN Patent

CN110054616B — 三嗪类idh抑制剂的制备方法

Assigned to Nanjing Sanhome Pharmaceutical Co Ltd · Expires 2021-11-23 · 4y expired

What this patent protects

本发明属于医药化学领域，涉及三嗪类IDH抑制剂的制备方法，具体地，涉及式I的(S)‑3‑(三氟甲基)‑1‑(4‑(6‑(三氟甲基)吡啶‑2‑基)‑6‑(2‑(三氟甲基)吡啶‑4‑氨基)‑1,3,5‑三嗪‑2‑基)吡咯烷‑3‑醇或其盐、水合物、溶剂合物或结晶的制备方法，

USPTO Abstract

本发明属于医药化学领域，涉及三嗪类IDH抑制剂的制备方法，具体地，涉及式I的(S)‑3‑(三氟甲基)‑1‑(4‑(6‑(三氟甲基)吡啶‑2‑基)‑6‑(2‑(三氟甲基)吡啶‑4‑氨基)‑1,3,5‑三嗪‑2‑基)吡咯烷‑3‑醇或其盐、水合物、溶剂合物或结晶的制备方法，

Drugs covered by this patent

Patent Metadata

Patent number
CN110054616B
Jurisdiction
CN
Classification
—
Expires
2021-11-23
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Sanhome Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.